Who invested in Syndex Bio?
Syndex Bio's investors include ARCH Venture Partners.

United Kingdom · Seed startup
Funding summaryUpdated 26 Oct 2026
$30Mraised across 3 rounds since 2024, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yetSEC filing: $16M sold, first sale Feb 2025
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yetSEC filing: $16M sold, first sale Feb 2025
Syndex Bio filed 2 raises, $14M in all. Filings say how much was sold and to how many investors; they never name the investors.
Syndex Bio's investors include ARCH Venture Partners.
Syndex Bio has raised $30M across 3 rounds since 2024.
Syndex Bio's most recent round was a Seed of $16M in Feb 2026.
Its most recent round, $16M in Feb 2026, is also its largest on record.
Syndex Bio's first round on record, in Feb 2026, was backed by ARCH Venture Partners.
Syndex Bio's latest named round is a Seed, in Feb 2026.
Syndex Bio is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.